Collaborate with Dynoma

Accelerating Discovery Through Strategic Partnerships

Unlock novel therapeutic targets and accelerate your pipeline by integrating Dynoma's dynamic biomolecular platforms into your research initiatives.

Flexible Engagement

Tailored Partnership Models

Dynoma offers various strategic frameworks to integrate our cutting-edge platforms, aligning with your research and business objectives.

Co-Development

Platform Licensing

Joint Research Programs

Shared risk and value creation through milestones tied to validated therapeutic targets and joint intellectual property.

Integrate our proprietary dynamic profiling technologies directly into your R&D pipeline with comprehensive support.

Leverage Dynoma's expert scientists and advanced instrumentation for sponsored research and assay development.

Industry Recognition

Dynoma's platform has fundamentally shifted how we approach target validation, revealing insights previously unattainable with static methods.

Ready to Explore Collaboration?

Connect with our business development team to discuss how Dynoma's platforms can accelerate your target validation and drug discovery efforts.